Jinhai Medical Technology (HKG:2225) received the results of the inquiry of the Securities and Futures Commission into the company's shareholding on
The results showed that 27 shareholders held 41.26% of the issued shares of the company and Chen Guobao, the company's chairman, held 48.94% of issued shares as of Nov. 20.
The shareholdings mentioned above make up 90.20% of the issued shares of the company leaving only 9.80% for other shareholders, a Monday Hong Kong bourse filing said.
SFC further mentioned that the company's shares' closing price rose by 77.65% to HK$9.06 on Nov. 20 from HK$5.10 on Sept. 13. The shares closed at HK$8.50 on Friday, representing an increase of 66.67% from HK$5.10 on Sept. 13.
免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。